// App-Quantinova.ai

: Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study

Researchers

Presenter

  • Bo Ding

Principal Investigators

  • Rebecca Zaha

  • Masato Ishida

  • Sophie Graham

  • Ai Hayashi

  • Sam Huse

  • Hana Müllerová

  • Shigeo Muro

Medical Centers

  • Evidera, Inc., London, United Kingdom

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca K.K., Osaka, Japan

  • AstraZeneca, Gothenburg, Sweden

  • Department of Respiratory Medicine, Hamamatsu Medical Center, Hamamatsu, Japan

  • Evidera, Seattle, United States of America

Locations

  • Sweden

  • United States

  • United Kingdom

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved